Long/short equity strategy focused on the global healthcare industry. This strategy invests in all industry sub-sectors, including companies engaged in the delivery, distribution, wholesaling and outsourcing of healthcare products and services, medical technology and equipment, pharmaceuticals, specialty pharmaceuticals, biotechnology, genomics, diagnostics, and life sciences. The Investment Philosophy is premised on the view that specialist industry expertise and diligence are required to understand changes in the global healthcare industry based on evolving government regulation, healthcare technology and industry structure. The investment team applies fundamental research and modeling to identify material levers impacting businesses positively or negatively and which the market does not yet appreciate as measured against consensus views and asset valuation. The investment team applies a disciplined portfolio construction process, including a multi-factorial set of real-time position level inputs guided by absolute return objectives, implied volatility targets and liquidity requirements to structure and trade a portfolio of these long and short ideas.

Portfolio Manager

The Healthcare strategy is led by Emile Westergaard.